Publications by authors named "Rodanthi Fioretzaki"

Claim this Profile
T
The Interplay Between Esophageal Adenocarcinoma and Its Tumor Microenvironment: Toward Innovative Therapies.
Rodanthi Fioretzaki, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Charalampakis, Konstantinos Christofidis

Cells· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.
Maria Dimou, Rodanthi Fioretzaki, Calliope Zerzi, Eliana Konstantinou, John V Asimakopoulos

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin A2 in Tumors of the Gastrointestinal Tract, Liver, and Pancreas.
Konstantinos Christofidis, Alexandros Pergaris, Rodanthi Fioretzaki, Nikolaos Charalampakis, Emmanouil Ι Kapetanakis

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.
Bruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki, Emilia Corradini, Roberta Bove

Int J Mol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers.
Rodanthi Fioretzaki, Panagiotis Sarantis, Nikolaos Charalampakis, Konstantinos Christofidis, Adam Mylonakis

Biomedicines· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma.
Nikolaos Skouteris, Georgios Papageorgiou, Rodanthi Fioretzaki, Dimitrios Schizas, Stylianos Kykalos

Immunotherapy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Anna Montanaro, Samuel Kitara, Elisa Cerretani, Matteo Marchesini, Chiara Rompietti, Rodanthi Fioretzaki

Cell Death Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Nikolaos Charalampakis, Sergios Tsakatikas, Dimitrios Schizas, Stylianos Kykalos, Maria Tolia, Rodanthi Fioretzaki

World J Gastrointest Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of current results with the vincristine-irinotecan-temozolomide combination with or without bevacizumab in pediatric, adolescence and adult solid tumors.
Sergios Tsakatikas, George Papageorgiou, Rodanthi Fioretzaki, Christos Kosmas

Crit Rev Oncol Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for cholangiocarcinoma: a 2021 update.
Nikolaos Charalampakis, Georgios Papageorgiou, Sergios Tsakatikas, Rodanthi Fioretzaki, Christo Kole

Immunotherapy· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab.
Georgios I Papageorgiou, Sergios A Tsakatikas, Rodanthi G Fioretzaki, Christos Kosmas

Anticancer Drugs· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma.
Aikaterini Mastoraki, Dimitrios Schizas, Pigi Vlachou, Nikoleta Maria Melissaridou, Nikolaos Charalampakis, Rodanthi Fioretzaki

Mol Diagn Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
Giulia Mazzaschi, Paola Bordi, Rodanthi Fioretzaki, Letizia Gnetti, Gianluca Milanese

Clin Lung Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis